Selective hyposmia in Parkinson disease: Association with hippocampal dopamine activity

Neuroscience Letters

Volumn 447, Issue 1, 2008, Pages 12-16

  Bohnen, Nicolaas I ^a,b   Gedela, Satyanarayana ^a   Herath, Priyantha ^a   Constantine, Gregory M ^c   Moore, Robert Y ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

11C CFT; Amygdala; Dopamine; Hippocampus; Parkinson disease; PET; Smell

Indexed keywords

DOPAMINE; DOPAMINE TRANSPORTER;

ADULT; AGED; AMYGDALOID NUCLEUS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; FEMALE; HIPPOCAMPUS; HUMAN; HYPOSMIA; MALE; OLFACTORY DISCRIMINATION; OUTCOME ASSESSMENT; PARKINSON DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN BINDING;

AGED; CARBON ISOTOPES; COCAINE; DOPAMINE; DOPAMINE UPTAKE INHIBITORS; FEMALE; HIPPOCAMPUS; HUMANS; MALE; MENTAL STATUS SCHEDULE; MIDDLE AGED; MODELS, BIOLOGICAL; NEURAL PATHWAYS; OLFACTION DISORDERS; PARKINSON DISEASE;

EID: 54249119573     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2008.09.070     Document Type: Article

References (39)

1. Albin R.L., Koeppe R.A., Bohnen N.I., Wernette K., Kilbourn M.A., and Frey K.A. Spared caudal brainstem SERT binding in early Parkinson's disease. J. Cereb. Blood Flow Metab. 28 (2008) 441-444
2. 11C]raclopride. Mov. Disord. 12 (1997) 33-38
3. Bjorklund A., and Dunnett S.B. Dopamine neuron systems in the brain: an update. Trends Neurosci. 30 (2007) 194-202
4. Bohnen N.I., Gedela S., Kuwabara H., Constantine G.M., Mathis C.A., Studenski S.A., and Moore R.Y. Selective hyposmia and nigrostriatal dopaminergic denervation in Parkinson's disease. J. Neurol. 254 (2007) 84-90
5. Braak H., Del Tredici K., Rub U., de Vos R.A., Jansen Steur E.N., and Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol. Aging 24 (2003) 197-211
6. Casteels C., Lauwers E., Bormans G., Baekelandt V., and Van Laere K. Metabolic-dopaminergic mapping of the 6-hydroxydopamine rat model for Parkinson's disease. Eur. J. Nucl. Med. Mol. Imaging 35 (2008) 124-134
7. Coopersmith R., Weihmuller F.B., Kirstein C.L., Marshall J.F., and Leon M. Extracellular dopamine increases in the neonatal olfactory bulb during odor preference training. Brain Res. 564 (1991) 149-153
8. Daum R.F., Sekinger B., Kobal G., and Lang C.J.G. Riechprüfung mit "sniffin' sticks" zur klinischen Diagnostic des Morbus Parkinson. Nervenarzt 71 (2000) 643-650
9. Doty R.L., Deems D.A., and Stellar S. Olfactory dysfunction in parkinsonism: a general deficit unrelated to neurologic signs, disease stage, or disease duration. Neurology 38 (1988) 1237-1244
10. Doty R.L., Li C., Bagla R., Huang W., Pfeiffer C., Brosvic G.M., and Risser J.M. SKF 38393 enhances odor detection performance. Psychopharmacology (Berl) 136 (1998) 75-82
11. Doty R.L., and Risser J.M. Influence of the D-2 dopamine receptor agonist quinpirole on the odor detection performance of rats before and after spiperone administration. Psychopharmacology (Berl) 98 (1989) 310-315
12. Doty R.L., Stern M.B., Pfeiffer C., Gollomp S.M., and Hurtig H.I. Bilateral olfactory dysfunction in early stage treated and untreated idiopathic Parkinson's disease. J. Neurol. Neurosurg. Psychiatry 55 (1992) 138-142
13. Double K.L., Rowe D.B., Hayes M., Chan D.K., Blackie J., Corbett A., Joffe R., Fung V.S., Morris J., and Halliday G.M. Identifying the pattern of olfactory deficits in Parkinson disease using the brief smell identification test. Arch. Neurol. 60 (2003) 545-549
14. Dujardin K., Duhamel A., Becquet E., Grunberg C., Defebvre L., and Destee A. Neuropsychological abnormalities in first degree relatives of patients with familial Parkinson's disease. J. Neurol. Neurosurg. Psychiatry 67 (1999) 323-328
15. Goto Y., and Grace A.A. Dopamine modulation of hippocampal-prefrontal cortical interaction drives memory-guided behavior. Cereb. Cortex 18 (2008) 1407-1414
16. Hawkes C.H. Parkinson's disease and aging: same or different process?. Mov. Disord. 23 (2008) 47-53
17. Hawkes C.H., Del Tredici K., and Braak H. Parkinson's disease: a dual-hit hypothesis. Neuropathol. Appl. Neurobiol. 33 (2007) 599-614
18. Hawkes C.H., and Shephard B.C. Selective anosmia in Parkinson's disease?. Lancet 341 (1993) 435-436
19. Herting B., Schulze S., Reichmann H., Haehner A., and Hummel T. A longitudinal study of olfactory function in patients with idiopathic Parkinson's disease. J. Neurol. 255 (2008) 367-370
20. Hsia A.Y., Vincent J.D., and Lledo P.M. Dopamine depresses synaptic inputs into the olfactory bulb. J. Neurophysiol. 82 (1999) 1082-1085
21. Hughes A.J., Daniel S.E., Kilford L., and Lees A.J. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinicopathologic study of 100 cases. J. Neurol. Neurosurg. Psychiatry 55 (1992) 181-184
22. Huisman E., Uylings H.B., and Hoogland P.V. A 100% increase of dopaminergic cells in the olfactory bulb may explain hyposmia in Parkinson's disease. Mov. Disord. 19 (2004) 687-692
23. 11C]DASB positron emission tomography studies of the serotonin transporter in human brain. J. Cereb. Blood Flow Metab. 23 (2003) 1096-1112
24. Jellinger K.A. A critical reappraisal of current staging of Lewy-related pathology in human brain. Acta Neuropathol. 116 (2008) 1-16
25. Kalaitzakis M.E., Graeber M.B., Gentleman S.M., and Pearce R.K. The dorsal motor nucleus of the vagus is not an obligatory trigger site of Parkinson's disease: a critical analysis of alpha-synuclein staging. Neuropathol. Appl. Neurobiol. 34 (2008) 284-295
26. Kareken D.A., Mosnik D.M., Doty R.L., Dzemidzic M., and Hutchins G.D. Functional anatomy of human odor sensation, discrimination, and identification in health and aging. Neuropsychology 17 (2003) 482-495
27. Kranick S.M., and Duda J.E. Olfactory dysfunction in Parkinson's disease. Neurosignals 16 (2008) 35-40
28. Pellegrino D., Cicchetti F., Wang X., Zhu A., Yu M., Saint-Pierre M., and Brownell A.L. Modulation of dopaminergic and glutamatergic brain function: PET studies on Parkinsonian rats. J. Nucl. Med. 48 (2007) 1147-1153
29. Pignatelli A., and Belluzzi O. Cholinergic modulation of dopaminergic neurons in the mouse olfactory bulb. Chem. Senses 33 (2008) 331-338
30. Potagas C., Dellatolas G., Ziegler M., Leveteau J., Bathien N., Mac Leod P., and Rondot P. Clinical assessment of olfactory dysfunction in Parkinson's disease. Mov. Disord. 13 (1998) 394-399
31. Radloff L.S. The CES-D scale: a self-report depression scale for research in the general population. Appl. Psychol. Meas. 1 (1977) 385-401
32. 99mTc]TRODAT-1 SPECT imaging correlates with odor identification in early Parkinson disease. Neurology 64 (2005) 1716-1720
33. Silveira-Moriyama L., Williams D., Katzenschlager R., and Lees A.J. Pizza, mint, and licorice: smell testing in Parkinson's disease in a UK population. Mov. Disord. 20 Suppl. 10 (2005) P471
34. Tillerson J.L., Caudle W.M., Parent J.M., Gong C., Schallert T., and Miller G.W. Olfactory discrimination deficits in mice lacking the dopamine transporter or the D2 dopamine receptor. Behav. Brain Res. 172 (2006) 97-105
35. Vermetten E., Schmahl C., Southwick S.M., and Bremner J.D. Positron tomographic emission study of olfactory induced emotional recall in veterans with and without combat-related posttraumatic stress disorder. Psychopharmacol. Bull. 40 (2007) 8-30
36. Wang J., Eslinger P.J., Smith M.B., and Yang Q.X. Functional magnetic resonance imaging study of human olfaction and normal aging. J. Gerontol. A Biol. Sci. Med. Sci. 60 (2005) 510-514
37. Wei C.J., Linster C., and Cleland T.A. Dopamine D(2) receptor activation modulates perceived odor intensity. Behav. Neurosci. 120 (2006) 393-400
38. Westermann B., Wattendorf E., Schwerdtfeger U., Husner A., Fuhr P., Gratzl O., Hummel T., Bilecen D., and Welge-Luessen A. Functional imaging of the cerebral olfactory system in patients with Parkinson's disease. J. Neurol. Neurosurg. Psychiatry 79 (2008) 19-24
39. Yue E.L., Cleland T.A., Pavlis M., and Linster C. Opposing effects of D1 and D2 receptor activation on odor discrimination learning. Behav. Neurosci. 118 (2004) 184-190